Moxalactam (sodium salt)

Moxalactam (Latamoxef) sodium salt is a synthetic oxa-β-lactam antibiotic. Moxalactam sodium salt has a broad spectrum of activity against Gram-positive and Gram-negative aerobic and anaerobic bacteria. Moxalactam sodium salt inhibits production of β-lactamases[1].

Product Specifications

CAS Number

[64953-12-4]

Product Name Alternative

Latamoxef (sodium) ; Lamoxactam (sodium) ; LY-127935 (sodium)

UNSPSC

12352005

Hazard Statement

H317, H334

Target

Antibiotic; Bacterial; Beta-lactamase

Type

Reference compound

Related Pathways

Anti-infection

Applications

COVID-19-immunoregulation

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/Moxalactam-sodium-salt.html

Purity

97.39

Solubility

DMSO : 200 mg/mL (ultrasonic)

Smiles

O=C(C(N12)=C(CSC3=NN=NN3C)CO[C@]2([H])[C@](OC)(NC(C(C(O[Na])=O)C4=CC=C(O)C=C4)=O)C1=O)O[Na]

Molecular Formula

C20H18N6Na2O9S

Molecular Weight

564.44

Precautions

H317, H334

References & Citations

[1]Carmine AA, et al. Moxalactam (latamoxef) . A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs. 1983 Oct;26 (4) :279-333.|[2]Goto S. In vitro and in vivo antibacterial activity of moxalactam, an oxa-β-lactam antibiotic. Clinical Infectious Diseases, 1982, 4 (Supplement_3) : S501-S510.